Table 2.
Fucoidan source | Characteristics | Studies | Dose | Species | Results | Ref. |
---|---|---|---|---|---|---|
Undaria pinnatifida | 53% total sugar 7.4% sulfate 27% Uronic acid 54% fucose 35% galactose |
Acute in vivo Ames test Bone marrow micronucleus |
1000 mg/kg body weight per day for 28 days | Sprague Dawley rats |
Not toxic to 1000 mg/kg bw; Increase in ALT at 200 mg/kg | Chung 2010 [25] |
Laminaria japonica | Fucoidan Fraction MW average “10–300 kD” |
Oral dosing in experimental model; Toxicity by clinical observation | Escalation doses up to 20 mg/kg | Dogs with hemophilia A; Rats | No clinical toxicity | Prasad 2008 [31] |
Laminaria japonica | Fluorescent labeled fucoidan | Subcutaneous | 5 mg/kg | Rat | Half life 83 min | Prasad 2008 [31] |
Laminaria japonica | MW average 189 kDa Fucose 28% sulfate 29% total sugasr 48% |
Acute and sub-chronic toxicity | 300, 900 and 2500 mg/kg bw to 6 months | Wistar Rats | Not toxic to 300 mg/kg bw Prolonged clotting at 900 and 1200 mg/kg bw | Li 2005 [26] |
Undaria pinnatifida | 64.4 ± 6.0% fucose, 31.9 ± 4.7% galactose, 3.6 ± 1.3% mannose, and 31.7 ± 2.2% sulfate | Genotoxicity Bacterial mutation Bone marrow Micronucleus formation |
Up to 2000 mg/kg/bw orally | Sprague Dawley rats | Fucoidan presents no significant genotoxic concern. | Kim 2010 [32] |
Undaria pinnatifida | 64.4 ± 6.0% fucose, 31.9 ± 4.7% galactose, 3.6 ± 1.3% mannose, and 31.7 ± 2.2% sulfate | Toxicty measures—body weight, ophthalmoscopy urinalysis, hematology, and histopathology; Clotting paramaters; Prothrombin time or activated partial thromboplastin time | 1350 mg/kg bw/day for 4 weeks orally | Sprague Dawley rats | No changes to No change to prothrombin time or activated partial thromboplastin time | Kim 2009 [30] |
Undaria pinnatifida | 75% fucoidan | Full blood count, clinical biochemistry | 3 g per day for 12 days | Human | No toxicity noted | Irhimeh 2005, 2007, 2009 [19,28,29] |
Fucus vesiculosis Macrocystis pyrifera Laminaria japonica |
75% total fucoidan | Full blood count, clinical biochemistry | 0.1 and 1 g for 84 days | Human | No toxicity | Myers 2010 [27] |
Fucus vesiculosis Macrocystis pyrifera Laminaria japonica |
75% total fucoidan | Full blood count, clinical biochemistry | 0.1 and 1 g for 28 days | Human | No toxicity | Myers 2011 [33] |
Cladisiphon sp. | 85% fucoidan | Patients with HTLV1 were treated clinically | 6 g per day up to 13 months | Human | Four patients diarrhea; No other toxicity noted; Reduction in viral load | Araya 2011 [34] |